MENU

NEWSLETTER SIGN UP  CONTACT US

Nkarta Therapeutics

Nkarta Therapeutics

Updated March 2021.

88%

Employees say this is a great place to work

Company Overview

About The Company

Nkarta is a clinical-stage biotechnology company developing allogeneic, off the shelf natural killer (NK) cell therapies for cancer. Founded in 2015 at the birthplace of biotechnology in South San Francisco, CA, Nkarta became a public company (Nasdaq TX) in 2020.

COMPANY SIZE

99 U.S.-based Employees
(Small)

Industry

Biotechnology & Pharmaceuticals

HQ Location

South San Francisco, CA, US

Employee Demographics

Tenure

Company Culture at Nkarta Therapeutics

The employee experience below at Nkarta Therapeutics, compared to a typical company.

Learn More

88% of employees at Nkarta Therapeutics say it is a great place to work compared to 57% of employees at a typical U.S.-based company.

  • Nkarta Therapeutics
    • 88%
  • Typical Company
    • 57%

Source: Great Place To Work® 2021 Global Employee Engagement Study.

97%
I believe management would lay people off only as a last resort.
96%
People here are given a lot of responsibility.
96%
Management is honest and ethical in its business practices.
95%
Our executives fully embody the best characteristics of our company.
94%
Management is competent at running the business.

Why Work at Nkarta Therapeutics?

See what employees say about what makes Nkarta Therapeutics a great workplace. These words are drawn from employee comments on the Trust Index™ survey.

Best Workplaces Lists

Great Place To Work® is proud to recognize Nkarta Therapeutics

2024

2023